GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medivir AB (OTCPK:MVRBF) » Definitions » Price-to-Operating-Cash-Flow

Medivir AB (Medivir AB) Price-to-Operating-Cash-Flow : (As of May. 11, 2024)


View and export this data going back to . Start your Free Trial

What is Medivir AB Price-to-Operating-Cash-Flow?

As of today (2024-05-11), Medivir AB's share price is $0.82. Medivir AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.13. Hence, Medivir AB's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Medivir AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Medivir AB's highest Price-to-Operating-Cash-Flow Ratio was 979.09. The lowest was 1.80. And the median was 5.60.

MVRBF's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 26.92
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Medivir AB's Cash Flow from Operations per share for the three months ended in Mar. 2024 was $-0.06. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.13.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 15.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 33.40% per year.

During the past 13 years, Medivir AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 156.10% per year. The lowest was -23.70% per year. And the median was 14.35% per year.


Medivir AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Medivir AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medivir AB Price-to-Operating-Cash-Flow Chart

Medivir AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medivir AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Medivir AB's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Medivir AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medivir AB's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medivir AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Medivir AB's Price-to-Operating-Cash-Flow falls into.



Medivir AB Price-to-Operating-Cash-Flow Calculation

Medivir AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.82/-0.132
=

Medivir AB's Share Price of today is $0.82.
Medivir AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.13.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Medivir AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Medivir AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Medivir AB (Medivir AB) Business Description

Industry
Traded in Other Exchanges
Address
Lunastigen 5, PO Box 1086, 2nd floor, Huddinge, SWE, 141 22
Medivir AB develops drugs with a focus on cancers where there are medical needs. The company invests in indication areas where available treatment methods are limited or lacking and there are opportunities to offer significant improvements to patients. Medivir focuses on the development of MIV-818, a prodrug that has been designed to provide a targeted anti-tumor effect in the liver while minimizing any side effects. Birinapant, a SMAC mimetic, has been out-licensed for development in combination with IGM antibodies for the treatment of solid tumors.